Term |
Explanation |
Anti‐ Vascular endothelial growth factor (Anti‐VEGF) |
The drug that suppress or inhibit the effect of VEGF. |
Cryotherapy |
Cryotherapy, also called cryoablation is a minimally invasive treatment that uses extreme cold to freeze and destroy diseased tissue. During cryotherapy, liquid nitrogen or argon gas flows into a needle‐like applicator (a cryoprobe) creating intense cold that is placed in contact to diseased tissue. |
Diathermy |
Using high‐frequency electrical current to produce deep heating of tissue. |
Intravitreal anti‐VEGF |
Injection of anti‐VEGF into vitreous cavity. |
Laser photocoagulation |
Using laser light to treat certain disorders at the back of the eye. |
New vessels |
This term is used to signify the abnormal growth of vessels in the eye in response to a need for more oxygen. On the optic disc ‐ new vessels disc 'NVD', on the retina ‐ new vessels elsewhere 'NVE'. Generally, these new blood vessels do not have the normal integrity of blood vessel and tends to bleed. |
Regression |
New vessels stop growing or obliterated. |
Retinal detachment |
The retina has fallen away from its correct position at the back of the eye, which leads to a defect in the field of vision and ultimately loss of vision. |
Retinopathy |
Disease of the retina, for example, diabetic retinopathy is disease of the retina secondary to diabetes, sickle retinopathy is disease of retina secondary to sickle cell disease. |
Vitrectomy |
Surgical removal of the vitreous. |
Vitreous |
Soft gelatinous material that fills the back of the eye and sits behind the lens. |
Vitreous haemorrhage |
Bleeding into the vitreous cavity. |
Vascular endothelial growth factor (VEGF) |
A substance produced from retina particularly when the oxygen supply is insufficient. It causes growth of new blood vessels in the retina. |